NIM
GNMK
Needham Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,443,400
| Closed | -$5.95M | – | 119 |
|
|
2020
Q1 | $5.95M | Buy |
1,443,400
+648,400
| +82% | +$2.67M | 1.68% | 17 |
|
|
2019
Q4 | $3.82M | Buy |
795,000
+545,000
| +218% | +$2.62M | 1.04% | 32 |
|
|
2019
Q3 | $1.52M | Buy |
250,000
+60,000
| +32% | +$364K | 0.49% | 45 |
|
|
2019
Q2 | $1.23M | Sell |
190,000
-50,500
| -21% | -$328K | 0.41% | 51 |
|
|
2019
Q1 | $1.71M | Sell |
240,500
-40,000
| -14% | -$284K | 0.58% | 42 |
|
|
2018
Q4 | $1.36M | Buy |
280,500
+20,500
| +8% | +$99.7K | 0.51% | 43 |
|
|
2018
Q3 | $1.91M | Buy |
260,000
+30,000
| +13% | +$221K | 0.58% | 47 |
|
|
2018
Q2 | $1.47M | Buy |
230,000
+50,000
| +28% | +$319K | 0.41% | 53 |
|
|
2018
Q1 | $979K | Hold |
180,000
| – | – | 0.28% | 58 |
|
|
2017
Q4 | $750K | Buy |
180,000
+123,000
| +216% | +$513K | 0.2% | 68 |
|
|
2017
Q3 | $550K | Buy |
57,000
+7,000
| +14% | +$67.5K | 0.14% | 77 |
|
|
2017
Q2 | $592K | Buy |
+50,000
| New | +$592K | 0.16% | 75 |
|